Epidemiology of sarcopenia.
There are few epidemiological data to estimate the prevalence of sarcopenia, nor is there a standard of morbidity that defines the degree of disability and consequently the seriousness of this problem. This article reviews data on prevalence, examines different aspects of measurements, and discusses the policy ramifications of establishing a specific definition of sarcopenia.
Melton
L J
LJ
Department of Health Sciences Research, Mayo Clinic Rochester, Minn., USA.
Khosla
S
S
Riggs
B L
BL
D015502:Absorptiometry, Photon; D017677:Age Distribution; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000375:Aging / Q000473:pathology / Q000502:physiology; D000886:Anthropometry; D001823:Body Composition; D003404:Creatinine / Q000652:urine; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009133:Muscular Atrophy / Q000175:diagnosis / Q000453:epidemiology* / Q000209:etiology* / Q000378:metabolism; D015995:Prevalence; D014947:Wounds and Injuries / Q000209:etiology
D003404:Creatinine